Jubilant Pharmova Ltd 2009 SR
The report highlights Jubilant Organosys Limited's commitment to the triple bottom line approach during the 2008-09 fiscal year. Key achievements include the acquisition of Draxis Specialty Pharmaceuticals and Speciality Molecules Ltd, and the launch of the Jubilant Bhartia Foundation to manage social interventions. The company focused on energy and water conservation, successfully receiving approval for two Clean Development Mechanism projects. Notably, the company reported zero workplace fatalities despite expanded operations and continued its 'Muskan' project to support primary education in rural schools.
Company: Jubilant Pharmova Ltd
Sector: Manufacturing
Country: India
Year: 2009
Type: SR
Pages: 68
Back to company
Jubilant Pharmova Ltd
Corporate Sustainability Report
The report highlights Jubilant Organosys Limited's commitment to the triple bottom line approach during the 2008-09 fiscal year. Key achievements include the acquisition of Draxis Specialty Pharmaceuticals and Speciality Molecules Ltd, and the launch of the Jubilant Bhartia Foundation to manage social interventions. The company focused on energy and water conservation, successfully receiving approval for two Clean Development Mechanism projects. Notably, the company reported zero workplace fatalities despite expanded operations and continued its 'Muskan' project to support primary education in rural schools.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2009
Reporting Period
Apr 2008 - Mar 2009
Fiscal Year
2009
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees